TMDI - Titan Medical granted 180-day extension to regain compliance with Nasdaq's minimum bid price rule
- Titan Medical ( NASDAQ: TMDI ) has been granted an additional 180 calendar day period, through December 26, 2022, to evidence compliance with the US$1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market.
- If the company does not comply with the minimum bid price requirement during the 180-day grace period than its shares are subject to delisting.
- Th company was notified in December 2021 that the minimum bid price per share for its ordinary shares has been below $1.00 for a period of 30 consecutive business days and it no longer meets the minimum bid price requirements.
- Stock plunged ~66% over a period of one year.
For further details see:
Titan Medical granted 180-day extension to regain compliance with Nasdaq's minimum bid price rule